A group from Grossman School of Medicine, New York has reported on the efficacy of Pfizer’s current new coronavirus (COVDI-19) vaccine for B.1.1.7 (UK lineage variant) and B.1.351 (South African lineage variant).
https://www.biorxiv.org/content/10.1101/2021.02.05.430003v1
This blog site also contains a similar research result from other research groups (see article on February 6, 2021).
The Group’s reporting has a similar trend. The current Pfizer vaccine is not so affected by UK variant, but it seems certain that its effectiveness is likely to be significantly lower for South African variant.
